GOUT: Disease State and Management
Presented by Mita Adhya
 
Dec. 15, 2011
6:30pm Refreshments
7:00pm Dinner and Speaker
 
We apologize, but this meeting has been closed to technicians.
CEU Pending.

RSVP to William Urfer (616)381-2256 or william@swmpa.org by Dec. 12th.
 

Martell’s
(The former Black Swan)
3501 Greenleaf Blvd Kalamazoo, MI 49008

View Larger Map
 
Graciously Sponsored By
Scott Terry of URL Pharma

Dr Suresh N Rao
Director Of Medical Education Clinical And Regulatory Affairs
presents
Accuracy Through Technology

Monday, June 13, 2011
6:30PM Refreshments

7:00PM Dinner & Speaker

Martell’s
3501 Greenleaf Blvd
Kalamazoo, Michigan 49008

View Larger Map

2 CEU

RSVP to William Urfer at 381-2256 or email william@swmpa.org by Friday June 10th

Graciously sponsored by Anthony Trumblee Of Abbott

Fixed-Dose Triple Combination Therapy For Patients With
Uncontrolled Hypertension On Dual Combination Therapy
presented by
Kenneth Jamerson, Md
Professor Of Internal Medicine-University Of Michigan Health System Dept.

Thursday, June 2, 2011
6:30pm With Dinner And Speaker

Martell’s
3501 Greenleaf Blvd
Kalamazoo, Mi 49008

View Larger Map

2 CEU

RSVP to William Urfer 381-2256 or email william@swmpa.org or to Chad Aaberg 269-547-0225 By Wednesday, June 1st

Graciously Sponsored By Chad Aaberg Of Daiichi-Sankyo

Why We Worry: Understanding And Treating Anxiety Disorders
Presented by Mark Schneider, Ph.D

Monday, March 28, 2011

Clarion Hotel
3600 East Cork Street
Kalamazoo

View Larger Map

Check in at 8:15am, program runs at 9am to 4pm
Bring your own lunch.

6 hours live CEU

Registration is $79
Call 866-652-7414

For more information call William Urfer at 381-2256 or email william@swmpa.org

Sponsored by IBP

The FDA as given marketing approval to AstraZenica and Brystol Myers Squibb for their new combination product Kombiglyze XR. Kombiglyze XR is a once daily dose of extended-release metformin and saxaglyptin. Saxaglyptin was previously approved by itself as Onglyza. Saxaglyptin is a member of the new class of anti-diabetic drugs called dipeptidyl peptidase-4 inhibitors, of which Merck’s Januvia/Janumet may be a more familiar member. The drug will compete in the already crowded but important marketplace of oral therapies for type-2 diabetes. Both of the DPP-4 inhibitors and their metformin combinations are top-tier and require prior authorization on popular health plans such as Priority Health and Blue Cross/Blue Shield of Michigan.

more…

November 19, 2010:
The U.S. Food and Drug Administration (FDA) is recommending against continued prescribing and use of the pain reliever propoxyphene because new data show that the drug can cause serious toxicity to the heart, even when used at therapeutic doses. FDA has requested that companies voluntarily withdraw propoxyphene from the United States market.

Propoxyphene is an opioid pain reliever used to treat mild to moderate pain. It is sold under various names as a single-ingredient product (e.g., Darvon) and as part of a combination product with acetaminophen (e.g., Darvocet).

FDA’s recommendation is based on all available data including data from a new study that evaluated the effects that increasing doses of propoxyphene have on the heart (see Data Summary below). The results of the new study showed that when propoxyphene was taken at therapeutic doses, there were significant changes to the electrical activity of the heart: prolonged PR interval, widened QRS complex and prolonged QT interval. These changes, which can be seen on an electrocardiogram (ECG), can increase the risk for serious abnormal heart rhythms. FDA has concluded that the safety risks of propoxyphene outweigh its benefits for pain relief at recommended doses.

Additional Information for Healthcare Professionals
FDA recommends that healthcare professionals:

• Stop prescribing and dispensing propoxyphene-containing products to patients.
• Contact patients currently taking propoxyphene-containing products and ask them to discontinue the drug.
• Inform patients of the risks associated with propoxyphene.
• Discuss alternative pain management strategies other than propoxyphene with your patients.
• Be aware of the possible risk of cardiac conduction abnormalities (prolonged QT, PR, and QRS intervals) in patients taking propoxyphene and assess patients for these events if they present with any signs or symptoms of arrhythmia.
• Report any side effects with propoxyphene to FDA’s MedWatch program.

more…

Looking Beyond LDL-C: The Importance Of Lipid Management

Presented by Dr. Jesse Duranceau, D.O.
Promed Internal Medicine
Portage, Michigan

Thursday December 2nd 2010
6:30PM Refreshments
7:00PM Dinner and Speaker

CEU Pending.

RSVP to William Urfer (616)381-2256 or william@swmpa.org by November 29.

Webster’s Prime Steakhouse
inside the Raddison
100 West Michigan Avenue
Kalamazoo, MI
(Parking will be validated)

View Larger Map

Graciously sponsored by Eric Glover And Erin Rich of Abbott Laboratories

Hypertension & Recent Changes In Therapy

presented by
Dr. Niranjan Lal
Board Certified Nephrologist
Director Of Hypertension Clinic In Kalamazoo

Thursday, September 16
Martells
(Formerly The Black Swan)
3501 Greenleaf Blvd
Kalamazoo 49008

6:30pm Refreshments
7:00pm Dinner & Presentation
2 Hours Of CE Pending.

View Larger Map

RSVP to William Urfer (616)381-2256 or william@swmpa.org by September 13

Graciously sponsored by Dan Aaberg Of GlaxoSmithKline

Breast Health, Hormones, And Osteoporosis

presented by Lori B. Kanter DPM, Rd

Wed. Sept. 29,2010
8:30am To 3:30pm
WMU’s Fetzer Center
1903 W, Michigan Ave
Kalamazoo

Parking is free and there will be an hour lunch break. You may bring your own lunch.

6 Hours Of Live CE

Pre-Registration $86.00
Call 1-800-937-6878

Symptomatic Benign Prostatic Hyperplasia–A Progressive Disease
presented by Gregory Oldford MD

July 15, 2010
6:30PM Refreshments
7:00PM Dinner and presentation
at
The Beacon Club
5380 Portage Road

View Larger Map

2 CEU
RSVP To William Urfer by < a href="william@swmpa.org">email or call 381-2256 By Monday July 12th

Graciously Sponsored by

David Vliek of GSK

Cerebral Dominance
presented by Michael E. Howard , Phd

Wed July 28, 2010
8:30AM To 3:30PM
6 Live CEU

Fetzer Center
Western Michigan Unversity
1903 W. Michigan Ave

Lunch not provided, please bring your own.

Pre-Registration is $86 or $101.00 at the door.
To Pre-Register Call 1-800-937-6878

For more info call William Urfer At 381-2256 or email weu123@aol.com

New Type 2 Diabetes Therapy
Presented by Suzanne Rivkin, Pharm.D.

June 17, 2010

6:30PM Refreshments
7:00PM Dinner & Lecture

2 CEU of non-live CE

Great Lakes Shipping Company
4525 West KL Avenue
Kalamazoo, MI 49006

View Larger Map

RSVP to William Urfer at 381-2256 or via email before June 15th

Graciously Sponsored By Steve Kine of Santarus

Listening To Your Body
presented by William Sieber, Phd

Tuesday, May 4 2010

8:15AM Registation
9:00AM Program Starts
You May Bring You Own Lunch

Pre-Register At 866-652-7414
Cost is $85.00 for 6 Hours Of Live CEU

Clarion Hotel
3600 East Cork St
Kalamazoo, Michigan

View Larger Map

For more information call (269)381-2245 Or E-Mail William Urfer

Sponsored by IBP

Gain Control, Sustain Control: Managing Patients With Type 2 Diabetes

Presented by Ron Smolen, Pharm D, Rph
Research Medical Scientist
GlaxoSmithKline Pharmaceuticals

Thursday, April 15 2010

6:30PM Reception & Hors D’oeuvres
7:00PM Dinner & Lecture

2 CEU of non-live CE

Fetzer Center
On the campus of Western Michigan University

View Larger Map

RSVP To William Urfer At 381-2256 Or via email by April 11

Graciously sponsored by Dan Aaberg Of GlaxoSmithKline

Overview Of Pulmonary Arterial Hypertension
Presented by Sandra Chase, Pharm D.

Thursday, March 18, 2010
6:30pm Refreshments
7:00pm Dinner And Lecture

Webster’s Prime Steakhouse
100 West Michigan Avenue
Kalamazoo, MI 49007
Validated parking in ramp

View Larger Map

2 CEU

RSVP To William Urfer at (269)381-2256 or weu123@aol.com By March 15th

Graciously sponsored by Amy Counts Of Gilead Sciences